Risk factors associated with 1-year mortality among patients with HIV-associated tuberculosis in areas with intermediate tuberculosis burden and low HIV prevalence

被引:9
|
作者
Chan, C. K. [1 ]
Wong, K. H. [2 ]
Lee, M. P. [3 ]
Chan, Kenny C. W. [4 ]
Leung, C. C. [1 ]
Leung, Eric C. C. [1 ]
Chan, W. K. [4 ]
Mak, Ida K. Y. [1 ]
机构
[1] Dept Hlth, TB & Chest Serv, Ctr Hlth Protect, Hong Kong, Hong Kong, Peoples R China
[2] Dept Hlth, Ctr Hlth Protect, Head Off, Hong Kong, Hong Kong, Peoples R China
[3] Hosp Author, Dept Med, Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[4] Dept Hlth, Ctr Hlth Protect, Integrated Treatment Ctr, Special Prevent Programme, Hong Kong, Hong Kong, Peoples R China
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; DEATH; DETERMINANTS; ADULTS;
D O I
10.12809/hkmj187303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Data are limited regarding risk factors for mortality among patients with human immunodeficiency virus (HIV)-associated tuberculosis (TB) in areas with low HIV prevalence and intermediate TB burden, such as the Western Pacific region. This study aimed to assess such risk factors in Hong Kong, which has an intermediate TB burden and low HIV prevalence. Methods: We conducted a retrospective cohort analysis of adult patients reported to the Hong Kong TB-HIV Registry between 2006 and 2015. Baseline characteristics were compared with Kaplan-Meier estimates. Cox proportional hazards regression modelling was used to identify factors associated with mortality. Results: Of 299 patients studied, 21 (7.0%) died within 12 months of anti-TB treatment (median [interquartile range], 7.5 [3.8-10] months). The median age of death was 54 (interquartile range, 40.5-75.0) years. The cause of death was TB in five and unrelated to TB in the remaining 16. Cox proportional hazards regression showed that older age (adjusted hazard ratio=4.5; 95% confidence interval [CI]=1.4-14.9), history of drug addiction (4.6; 95% CI=1.6-13.0), and low baseline CD4 cell count of <50/mu L (2.9; 95% CI=1.1-7.7) were independent risk factors for death within 12 months. Conclusion: This study complements previous studies by providing information regarding risk factors associated with mortality among patients with HIV-associated TB in areas with intermediate TB burden and low HIV prevalence. The results from our study may guide targeted measures to improve survival in other areas with intermediate TB burden and low HIV prevalence, such as the Western Pacific region.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 50 条
  • [31] Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins
    Bonora, S.
    Mondo, A.
    Trentini, L.
    Calcagno, A.
    Lucchini, A.
    Di Perri, G.
    JOURNAL OF INFECTION, 2008, 57 (01) : 78 - 81
  • [32] Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis
    van der Plas, Helen
    Meintjes, Graeme
    Schutz, Charlotte
    Goliath, Rene
    Myer, Landon
    Baatjie, Dorothea
    Wilkinson, Robert J.
    Maartens, Gary
    Mendelson, Marc
    PLOS ONE, 2013, 8 (02):
  • [33] THE RISKS OF CONCURRENT TREATMENT WITH TENOFOVIR AND AMINOGLYCOSIDES IN PATIENTS WITH HIV-ASSOCIATED TUBERCULOSIS
    Kenyon, Chris
    Wearne, Nicci
    Burton, Rosie
    Meintjes, Graeme
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2011, (39) : 43 - 45
  • [34] Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis
    Azee, Adeboye
    Ndege, James
    Mutambayi, Ruffin
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2018, 7 (04) : 347 - 354
  • [35] Comment on: Risk factors associated with multidrug-resistant tuberculosis in areas with a moderate tuberculosis burden
    Toledo, John Patrick C.
    INTERNATIONAL HEALTH, 2024,
  • [36] Factors associated with unfavourable treatment outcomes in people with HIV-associated tuberculosis in Armenia, 2015 to 2019
    Gevorgyan, Lilit
    Grigoryan, Ruzanna
    Dumchev, Kostyantyn
    Akopyan, Kristina
    Khachatryan, Anush
    Kabasakalyan, Eduard
    Grigoryan, Trdat
    Safaryan, Marina
    Avagyan, Vardan
    Hasanova, Sayohat
    Matteelli, Alberto
    MONALDI ARCHIVES FOR CHEST DISEASE, 2021, 91 (01)
  • [37] HIV-associated tuberculosis among a cohort of heterosexual discordant couples in Lusaka, Zambia
    Kennedy, SB
    Campbell, J
    Hester, RA
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2002, 20 (04) : 289 - 296
  • [38] Factors Associated with Length of Hospital Stay among HIV Positive and HIV Negative Patients with Tuberculosis in Brazil
    Ferreira Goncalves, Maria Jacirema
    Ferreira, Alaidistania A.
    PLOS ONE, 2013, 8 (04):
  • [39] HIV risk factors among patients with tuberculosis - Botswana 1999
    Talbot, EA
    Kenyon, TA
    Moeti, TL
    Hsin, G
    Dooley, L
    El-Halabi, S
    Binkin, NJ
    INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (05) : 311 - 317
  • [40] Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study
    Schutz, Charlotte
    Barr, David
    Andrade, Bruno B.
    Shey, Muki
    Ward, Amy
    Janssen, Saskia
    Burton, Rosie
    Wilkinson, Katalin A.
    Sossen, Bianca
    Fukutani, Kiyoshi F.
    Nicol, Mark
    Maartens, Gary
    Wilkinson, Robert J.
    Meintjes, Graeme
    PLOS MEDICINE, 2019, 16 (07)